Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 32, 2021 - Issue 1
Submit an article Journal homepage
233
Views
3
CrossRef citations to date
0
Altmetric
Psoriasis and dermatitis

Is topical treatment effective for psoriasis in patients who failed topical treatment?

Nwanneka OkwunduCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Correspondence[email protected]
View further author information
,
Leah CardwellCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; View further author information
,
Abigail ClineCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; View further author information
,
Irma RichardsonCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; View further author information
&
Steven R. FeldmanCenter for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA; ;Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA; ;Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USAORCID Iconhttp://orcid.org/0000-0002-0090-6289View further author information
ORCID Icon
Pages 41-44 | Received 02 May 2019, Accepted 03 May 2019, Published online: 28 May 2019

References

  • Feldman SR, Fleischer AB, Jr, Cooper JZ. New topical treatments change the pattern of treatment of psoriasis: dermatologists remain the primary providers of this care. Int J Dermatol. 2000;39:41–44.
  • Menter A. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial. Cutis. 2007;80:12–19.
  • Saleem MD, Negus D, Feldman SR. Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial. J Dermatolog Treat. 2018;29:32–35.
  • Mraz S, Leonardi C, Colon LE, et al. Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis. J Dermatolog Treat. 2008;19:354–359.
  • Chiricozzi A, Pimpinelli N, Ricceri F, et al. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus. Dermatol Ther. 2017;30:1–10
  • Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212–216.
  • Alinia H, Moradi Tuchayi S, Smith JA, et al. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Br J Dermatol. 2017;176:759–764.
  • Keegan BR. Desoximetasone 0.25% Spray for the Relief of Scaling in Adults With Plaque Psoriasis. J Drugs Dermatol. 2015;14:835–840.
  • Beutner K, Chakrabarty A, Lemke S, et al. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. J Drugs Dermatol. 2006;5:357–360.
  • Mehta AB, Nadkarni NJ, Patil SP, et al. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol. 2016;82:371–378.
  • Blais L, Kettani F, Forget A, et al. Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence. Eur J Clin Pharmacol. 2017;73:91–97.
  • Storm A, Andersen SE, Benfeldt E, et al. One in 3 prescriptions are never redeemed: Primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.
  • Zschocke I, Mrowietz U, Karakasili E, et al. Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 2014;28 Suppl 2:4–9.
  • Mooney E, Rademaker M, Dailey R, et al. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australas J Dermatol. 2015;56:241–251.
  • Varada S, Tintle SJ, Gottlieb AB. Apremilast for the treatment of psoriatic arthritis. Expert Rev Clin Pharmacol. 2014;7:239–250.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.